Chemical Structure : Dasatinib hydrochloride
CAS No.: 854001-07-3
货号: PC-42427Not For Human Use, Lab Use Only.
A potent, orally bioavailable, dual Src/Abl kinase inhibitor with IC50 of 0.5, 0.4, 0.5 and <1 nM for Src, Lck, Yes and Bcr-Abl, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
200 mg | ¥520 | In stock | |
500 mg | ¥784.0 | In stock | |
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
A potent, orally bioavailable, dual Src/Abl kinase inhibitor with IC50 of 0.5, 0.4, 0.5 and <1 nM for Src, Lck, Yes and Bcr-Abl, respectively; exhibits two-log increased potency relative to imatinib and retains activity against 14 of 15 imatinib-resistant BCR-ABL mutants; prolongs survival of mice with BCR-ABL-driven disease and inhibits proliferation of BCR-ABL-positive bone marrow progenitor cells from patients with imatinib-sensitive and imatinib-resistant CML.
Blood Cancer
Approved
分子量 | 524.4665 | |
分子式 | C22H27Cl2N7O2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: 15 mg/mL |
|
Chemical Name/SMILES |
5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, hydrochloride (1:1) |
1. Shah NP, et al. Science. 2004 Jul 16;305(5682):399-401.
2. Schittenhelm MM, et al. Cancer Res. 2006 Jan 1;66(1):473-81.
3. Johnson FM, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6924-32.
4. Lombardo LJ, et al. J Med Chem. 2004 Dec 30;47(27):6658-61.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright